Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.25 USD | +0.88% |
|
+1.84% | +62.95% |
Jun. 05 | Harrow, Inc. Announces 52-Week Data from VEVYE ESSENCE-2 Open-Label Extension Study | CI |
Jun. 03 | Lake Street Raises Price Target on Harrow to $25 From $20, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.95% | 646M | |
+48.79% | 781B | |
-7.23% | 350B | |
+19.43% | 330B | |
+7.18% | 293B | |
+17.00% | 248B | |
+0.16% | 221B | |
+11.57% | 217B | |
+4.53% | 162B | |
-3.92% | 157B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- Harrow Health Q1 Core Net Loss Widens, Revenue Increases -- Shares Rise After-Hours